Phase I Trial of Concurrent Hyperfractionated Split Course Radiotherapy (HFx RT), Cisplatin (cDDP), and Paclitaxel in Patients with Recurrent, Previously Irradiated, or Treatment-Naïve Locally Advanced Upper Aerodigestive Malignancy-Reference-Cited by-同舟云学术

Phase I Trial of Concurrent Hyperfractionated Split Course Radiotherapy (HFx RT), Cisplatin (cDDP), and Paclitaxel in Patients with Recurrent, Previously Irradiated, or Treatment-Naïve Locally Advanced Upper Aerodigestive Malignancy

Published:2006-01 Issue:2 Volume:24 Page:164-173
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Langer Corey J.,Duffy Karen,Horwitz Eric M.,Litwin Samuel,Rosvold Elizabeth,Schol Jessie,Keenan Eileen,Nicolaou Nicos,Friedman Craig D.,Ridge John A.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/07357900500524421

Reference31 articles.

1. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

2. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate;Head & Neck;2014-01-31

2. Mutagenic evaluation of combined paclitaxel and cisplatin treatment in somatic cells of Drosophila melanogaster;Mutation Research/Genetic Toxicology and Environmental Mutagenesis;2010-02

3. Concurrent Chemotherapy and Re-irradiation for Locoregionally Recurrent Head and Neck Cancer;Seminars in Oncology;2008-06